Physician profile
Sammy Pak
NPI 1619075744
$1,632.02
in general payments reported to CMS, 2019-2025
12 companies · $84.55 in 2025
The $84.55 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $424 · 2021: $756 · 2022: $14.41 · 2023: $63.75 · 2024: $150 · 2025: $84.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284 · Education: $14.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.36 |
| Education | $14.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $615.96 | 2021-2023 | Cavitron |
| Align Technology, INC. | $441.54 | 2020-2025 | Itero Element 2, Invisalign |
| Henry Schein, INC. | $139.18 | 2019-2024 | |
| Ace Surgical Supply Co., INC. | $134.16 | 2021-2022 | |
| Envista Holdings Corporation | $115.12 | 2024-2025 | Maxcem Elite, Tf |
| Zimmer Biomet Holdings, INC. | $54.53 | 2019 | |
| Kerr Corporation | $35.10 | 2021-2023 | Harmonize |
| Ultradent Products INC | $32.18 | 2019-2021 | |
| Straumann USA LLC | $16.50 | 2020 | |
| Solventum Corporation | $16.39 | 2024 | 3m Relyx, Paradigm Temporization, 3m Scotchbond |
| Elevate Oral Care | $16.33 | 2019 | |
| Nobel Biocare USA | $15.03 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sammy Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.